|

Prospective Study of White Blood Cells

RECRUITINGSponsored by Quell Therapeutics Limited
Actively Recruiting
SponsorQuell Therapeutics Limited
Started2021-03-24
Est. completion2029-12-31
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04838171

Summary

The purpose of this study is to investigate white blood cells from volunteering donors to support the development of engineered regulatory T cell therapies.

Eligibility

Healthy volunteers accepted
No additional inclusion/ exclusion criteria will be applied by Quell other than those specified by the consenting institutions.

Conditions4

Autoimmune DiseasesInflammationLiver DiseaseRejection; Transplant, Liver

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.